PMID: 6404949May 1, 1983Paper

Freeze dried cryoprecipitate: a clinical evaluation

Journal of Clinical Pathology
H HambleyC R Prentice

Abstract

Freeze dried cryoprecipitate was used in the treatment of 14 patients with haemophilia A. The in vivo recovery was 91.2% which is comparable to that reported from other parts of Europe. The product was efficacious and no adverse effects were reported. Freeze dried cryoprecipitate is the high yield product of a low technology process and as such may be of value in reducing any possible shortfall in the factor VIII requirements of the haemophiliac population of the UK.

References

Jun 3, 1978·British Medical Journal·P JonesJ Stuart
Dec 30, 1965·The New England Journal of Medicine·J G Pool, A E Shannon
Feb 1, 1980·Vox Sanguinis·J P AllainJ P Soulier
Oct 1, 1981·Journal of Clinical Pathology·G MillganR Mitchell

❮ Previous
Next ❯

Citations

Nov 1, 1983·Journal of Clinical Pathology·G S Gabra, R Mitchell
Sep 1, 1988·Journal of Clinical Pathology·A G BennyE W Berry
Apr 15, 2000·Risk Analysis : an Official Publication of the Society for Risk Analysis·R C EwingR P Rechard
May 11, 2007·Ecology·Roland JanssonClemens Augspurger
May 24, 2018·Bioconjugate Chemistry·Joseph Fernandez-MoureJeremy W Cannon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.